Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC). Neuropsychopharmacology. 2024 –

Clinical Application of Cannabis Vaporization: Examining Safety and Best Practices. Cannabis and Cannabinoid Research. 2024 –

Cannabis vaporisation: Understanding products, devices, and risks. Drug and Alcohol Review. 2023 –

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes. Journal of Cannabis Research. 2023 –

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis and Cannabinoid Research. 2023 –

Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review. The Canadian Journal of Psychiatry. 2023 –

Exploring medical cannabis use in individuals with a traumatic brain injury. Exploration of Medicine. 2023 –

Applying a cannabis impairment framework to medical cannabis patients. Medicinal Usage of Cannabis and Cannabinoids. Academic Press; 2023

Cannabidiol-Associated Hepatotoxicity: A Systematic Review and Meta-Analysis. Journal of Internal Medicine. 2023 –

Are Younger Medical Cannabis Users at Risk? Comparing Patterns of Use and Mental Health in Younger and Older Medical Cannabis Dispensary Users. SCHOLINK Children and Teenagers. 2023 –

Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users. Psychiatry and Clinical Psychopharmacology. 2022 – DOI: 10.5152/pcp.2022.22358

Differences in those who prefer smoking cannabis to other consumption forms for mental health: what can be learned to promote safer methods of consumption? Cannabinoids and Mental Health Risks. 2022 –

A Clinical Framework for Assessing Cannabis-Related Impairment Risk. Frontiers in Psychiatry. 2022 –

A Clinical Framework for Evaluating Cannabis Product Quality and Safety. Cannabis and Cannabinoids Research. 2022 –

Rapid response to ‘Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline’. BMJ. 2021 –

Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research. 2021 –

Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine. 2021 –

Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Frontiers in Pharmacology. 2021 –

Duration of neurocognitive impairment with medical cannabis use: a scoping review. Frontiers in Psychiatry. 2021 –

Guidance in Authorizing Cannabis Products Within Primary Care © 2021 The College of Family Physicians of Canada

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. BMJ Open. 2020;10:e036114 –

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. BMC Psychiatry. 2019;19:335 –

Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018;49 –